지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 1 - 7 (7page)
이용수
초록· 키워드
오류제보하기
Real-world evidence (RWE) and randomized control trial (RCT) data are considered mutually complementary. However, compared with RCT, the outcomes of RWE continue to be assigned lower credibility. It must be emphasized that RWE research is a real-world practice that does not need to be executed as RCT research for it to be reliable. The advantages and disadvantages of RWE must be discerned clearly, and then the proper protocol can be planned from the beginning of the research to secure as many samples as possible. Attention must be paid to privacy protection. Moreover, bias can be reduced meaningfully by reducing the number of dropouts through detailed and meticulous data quality management. RCT research, characterized as having the highest reliability, and RWE research, which reflects the actual clinical aspects, can have a mutually supplementary relationship. Indeed, once this is proven, the two could comprise the most powerful evidence-based research method in medicine.
목차
등록된 정보가 없습니다.
참고문헌 (27)
참고문헌 신청
Garrison LP Jr / 2007 / Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report / Value Health 10(5):326~335
Kim HS / 2017 / Use of moderate-intensity statins for low-density lipoprotein cholesterol level above 190 mg/dL at baseline in Koreans / Basic Clin Pharmacol Toxicol 121(4):272~278
Kim HS / 2016 / Comparative analysis of the efficacy of low- and moderate-intensity statins in Korea / Int J Clin Pharmacol Ther 54(11):864~871
Jeong YJ / 2017 / Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea / J Clin Pharm Ther 42(3):292~300
Kweon S / 2014 / Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES) / Int J Epidemiol 43(1):69~77
Kim HS / 2017 / Use of moderate-intensity statins for low-density lipoprotein cholesterol level above 190 mg/dL at baseline in Koreans / Basic Clin Pharmacol Toxicol 121(4):272~278
Kim HS / 2016 / Comparative analysis of the efficacy of low- and moderate-intensity statins in Korea / Int J Clin Pharmacol Ther 54(11):864~871
Jeong YJ / 2017 / Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea / J Clin Pharm Ther 42(3):292~300
Kweon S / 2014 / Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES) / Int J Epidemiol 43(1):69~77
이 논문의 저자 정보
최근 본 자료
댓글(0)
0